Greetings from MyCancerHaven!

We wanted to update you on our recent activities.

Here are the latest posts last week:

‍Blogs :

ASH 2024 highlights: Comparing momelotinib with other JAK inhibitors in myelofibrosis.

Experts discuss current and emerging therapies for treating myelofibrosis.

ASH 2024 highlights: Key research findings in myelofibrosis treatment advancements.

Experts discuss momelotinib's utility, dosing, and safety for myelofibrosis anemia.

ASH 2024 highlights: Momelotinib for treating anemia in myelofibrosis patients.

ASH 2024 highlights: Expert selections on key myelofibrosis research advancements.

Expanding myelofibrosis treatment options: The role of momelotinib therapy.

‍Also at MCH the News and Tweets never stop flowing!

Join Us at www.mycancerhaven.org

‍The Team @ MCH

Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok

Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.